WinstonWınston
Back
Fresenius Medical Care AG & Co. KGaA logo

Fresenius Medical Care AG & Co. KGaA

FMS
55
Medical - Care Facilities · Healthcare
Exchange
New York Stock Exchange
Winston Score
55
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Good
Cash Flow
Strong
Stability
Good
Valuation
Strong
Dividends
Mixed

Winston Score History

The full picture

Fresenius Medical Care is the world's largest provider of kidney dialysis services and equipment. It runs thousands of dialysis clinics where patients with kidney failure come in several times a week to have their blood cleaned by machines. The company also makes and sells the dialysis machines, filters, and fluids used in those treatments.

Fresenius Medical Care earns money two ways: by charging patients and insurers for dialysis treatments at its clinics, and by selling dialysis products to hospitals and other care providers. It operates in over 40 countries, with a large portion of revenue coming from the United States, where government programs like Medicare pay for most dialysis care. Its size gives it a cost advantage, but the business faces real pressure from U.S. reimbursement rate changes, since government decisions about how much to pay per treatment directly affect how much money the company makes.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
27.0%
Modest — 27.0% gross margin
Profit after running costs
Operating Margin
9.6%
Modest — 9.6% operating margin
Return on the money invested
ROCE
9.4%
Below par — 9.4% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-0.5%
Shrinking sales (-0.5% YoY)
Profit growth
EPS YoY
+85.6%
Earnings growing fast (+85.6% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
6/8 quarters
Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
299%
Turns 299% of profit into real cash
Spare cash per sale
FCF Margin
9.1%
Modest free cash flow (9.1%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.60
Moderate — manageable debt (0.60)
Covers its interest
Interest Cover
4.94x
Adequate interest coverage (4.9x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
12.1x
no trend
Attractive valuation — P/E 12.1

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year
P/E vs Forward
+3.4
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (12.1 → 8.7)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
3.59%
no trend
Moderate income — 3.59% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record
Dividend Growth
+0.9%
no trend
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial